Launch of World’s first wearable, non-invasive, continuous, blood glucose estimation technology using Helo

Jan 10, 2017

news image

WRMT today announced that its research activity generating non-invasive, continuous blood glucose estimates have been found to be sufficiently accurate to allow WRMT to proceed to full integration of the algorithm in the Helo platform so WRMT can offer blood glucose estimation as a service in Q4’17 to Helo wearers who choose to pay an initial set-up fee and an ongoing monthly charge.  For more details, please click here.